150 related articles for article (PubMed ID: 6127169)
1. Assessment of renal function during high-dose cis-platinum therapy in patients with ovarian carcinoma.
Buamah PK; Howell A; Whitby H; Harpur ES; Gescher A
Cancer Chemother Pharmacol; 1982; 8(3):281-4. PubMed ID: 6127169
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of urinary N-acetyl-beta-D-glucosaminidase (NAG), alanine-aminopeptidase (AAP) and beta-2-microglobulin (beta 2M) in evaluating nephrotoxicity of gentamicin.
Gibey R; Dupond JL; Alber D; Leconte des Floris R; Henry JC
Clin Chim Acta; 1981 Oct; 116(1):25-34. PubMed ID: 6172216
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase in patients receiving amikacin or cis-platinum.
Diener U; Knoll E; Langer B; Rautenstrauch H; Ratge D; Wisser H
Clin Chim Acta; 1981 May; 112(2):149-57. PubMed ID: 6113066
[TBL] [Abstract][Full Text] [Related]
4. Comparison of renal function parameters in the assessment of cis-platin induced nephrotoxicity.
Verplanke AJ; Herber RF; de Wit R; Veenhof CH
Nephron; 1994; 66(3):267-72. PubMed ID: 7910667
[TBL] [Abstract][Full Text] [Related]
5. Follow-up study of enzymuria and beta 2 microglobulinuria during cis-platinum treatment.
Tirelli AS; Colombo N; Cavanna G; Mangioni C; Assael BM
Eur J Clin Pharmacol; 1985; 29(3):313-8. PubMed ID: 3908127
[TBL] [Abstract][Full Text] [Related]
6. [Urinary excretion of glycine.prolile dipeptidile aminopeptidase, N-acetyl-beta-D-glucosaminidase, alanine aminopeptidase and low molecular protein in patients with renal cell carcinoma].
Kitamura Y; Watanabe M; Komatsubara S; Sakata Y
Hinyokika Kiyo; 1990 May; 36(5):535-9. PubMed ID: 1698011
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of urinary N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase.
Hsu WS; Kao JT; Chen JS
Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):407-9. PubMed ID: 2571671
[TBL] [Abstract][Full Text] [Related]
8. [Determination of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion as a parameter of nephrotoxicity due to cis-platin and the effect of fosfomycin (FOM) on its nephrotoxicity].
Matsuoka R; Inoue T; Miyamura K; Mizutani K; Koike S; Mori H; Kigawa T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2037-44. PubMed ID: 3794453
[TBL] [Abstract][Full Text] [Related]
9. Significance of the measurement of urinary alanine aminopeptidase and N-acetyl-beta-D-glucosaminidase activity in evaluating patients with essential hypertension.
Kohno M; Kanayama Y; Yasunari K; Kawarabayashi T; Murakawa K; Takeuchi K; Inoue T; Takeda T
Clin Exp Hypertens A; 1985; 7(10):1347-60. PubMed ID: 2866856
[TBL] [Abstract][Full Text] [Related]
10. Enzyme activities of urinary alanine aminopeptidase (AAP) and N-acetyl-beta-D-glucosaminidase (NAG) in healthy dogs.
Reusch C; Vochezer R; Weschta E
Zentralbl Veterinarmed A; 1991 Mar; 38(2):90-8. PubMed ID: 1677227
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of urinary alanine aminopeptidase and N-acetyl-beta-D-glucosaminidase in comparison to alpha 1-microglobulin as a marker in evaluating tubular dysfunction in glomerulonephritis patients.
Holdt-Lehmann B; Lehmann A; Korten G; Nagel H; Nizze H; Schuff-Werner P
Clin Chim Acta; 2000 Jul; 297(1-2):93-102. PubMed ID: 10841912
[TBL] [Abstract][Full Text] [Related]
12. Cumulative renal tubular damage associated with cisplatin nephrotoxicity.
Goren MP; Wright RK; Horowitz ME
Cancer Chemother Pharmacol; 1986; 18(1):69-73. PubMed ID: 2875808
[TBL] [Abstract][Full Text] [Related]
13. Comparison of methods of evaluating nephrotoxicity of cis-platinum.
Jones BR; Bhalla RB; Mladek J; Kaleya RN; Gralla RJ; Alcock NW; Schwartz MK; Young CW; Reidenberg MM
Clin Pharmacol Ther; 1980 Apr; 27(4):557-62. PubMed ID: 6987030
[TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of urinary alanine aminopeptidase in the patients with diabetes mellitus-comparison among AAP microalbumin and N-acetyl-beta-D-glucosaminidase].
Nakamura S
Hokkaido Igaku Zasshi; 1991 Jul; 66(4):522-33. PubMed ID: 1680783
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase in advanced neuroblastoma patients receiving cis-diamminedichloroplatinum(II).
Ikeda H; Nagashima K; Okumura H; Takahashi A; Matsuyama S; Nagamachi Y
Eur J Surg Oncol; 1988 Feb; 14(1):17-20. PubMed ID: 3278937
[TBL] [Abstract][Full Text] [Related]
16. Urinary endothelin-1-like immunoreactivity in young male patients with testicular cancer treated by cis-platinum: comparison with other urinary parameters.
Takeda M; Komeyama T; Tsutsui T; Mizusawa T; Go H; Hatano A; Tanikawa T
Clin Sci (Lond); 1994 Jun; 86(6):703-7. PubMed ID: 7520380
[TBL] [Abstract][Full Text] [Related]
17. Chronic renal tubular effects in relation to urine cadmium levels.
Mueller PW; Smith SJ; Steinberg KK; Thun MJ
Nephron; 1989; 52(1):45-54. PubMed ID: 2565539
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of methods for evaluating the nephrotoxicity of cisplatin].
Suzumori K; Yasui Y; Suzumori K; Yagami Y; Seki T
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2251-6. PubMed ID: 3044273
[TBL] [Abstract][Full Text] [Related]
19. Urinary excretion of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase during pregnancy.
Strigini F; Melis GB; Gasperini M; Ronca G; Palmieri L; Fioretti P
Int J Gynaecol Obstet; 1989 Jan; 28(1):9-12. PubMed ID: 2565837
[TBL] [Abstract][Full Text] [Related]
20. Urinary excretion of three specific renal tubular enzymes in patients treated with nonsteroidal anti-inflammatory drugs (NSAID).
Zafirovska KG; Bogdanovska SV; Marina N; Gruev T; Lozance L
Ren Fail; 1993; 15(1):51-4. PubMed ID: 8095099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
